Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-1141P is a pseudogene copy of the U6 small nuclear RNA gene, which was likely formed by retrotransposition or duplication followed by loss of function[6][5]. The parental gene, U6 snRNA, is a crucial RNA component within the spliceosome, driving pre-mRNA splicing in eukaryotic cells and highly conserved across species[1][3]. In contrast, pseudogenes such as RNU6-1141P no longer function in splicing or other cellular processes. Mammalian genomes contain many U6 snRNA pseudogenes, which are considered non-coding, lack protein products, and generally have no regulatory or disease relevance unless otherwise demonstrated[6][5]. Currently, there is no evidence that RNU6-1141P is transcribed, functional, or clinically relevant as a therapeutic target or biomarker.
None (does not encode a functional molecule)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 1141, pseudogene (RNU6-1141P).